regorafenib tablet

DRUG2 trials

Sponsors

Sun Yat-sen University, Gustave Roussy, Cancer Campus, Grand Paris

Conditions

Colorectal CancerEwing Sarcoma

Phase 1

JS001 Combined With Regorafenib in Patients With Advanced Colorectal Cancer

Sun Yat-sen UniversityColorectal Cancer

Start: 2019-03-12End: 2021-11-20Updated: 2020-05-12

Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma

Active, not recruitingNCT05830084

Gustave Roussy, Cancer Campus, Grand ParisEwing Sarcoma

Start: 2023-06-16End: 2027-10-31Updated: 2026-01-06

Related Papers

Phase Ib study of the combination of regorafenib with conventional chemotherapy in patients with newly diagnosed multi-metastatic Ewing sarcoma: The Rego-Inter-Ewing-1 study.

Journal of Clinical Oncology2025-05-281 citations

Regorafenib alone or in combination with high/low-dose radiotherapy plus toripalimab as third-line treatment in patients with metastatic colorectal cancer: protocol for a prospective, randomized, controlled phase II clinical trial (SLOT)

Frontiers in Oncology2023-10-054 citations

Real-world outcomes of regorafenib combined with immune checkpoint inhibitors in patients with advanced or metastatic microsatellite stable colorectal cancer: A multicenter study.

2021-10-2420 citations